Financials

  • Market Capitalization 641.19 M
  • Employee 146
  • Founded 2019
  • CEO N/A
  • Website www.primemedicine.com
  • Headquarter Delaware, United States
  • FIGI BBG011RT3R55
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.57
Fiyat/satışlar oranı
111.44

Prime Medicine, Inc. - Common Stock

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

Haberler